Concord Biotech Limited has informed the Exchange about Link of Recording
CONCORDBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Concord Biotech has shared the audio recording link of its earnings call held on February 12, 2026 at 3:30 PM IST for the third quarter and nine months ended December 31, 2025. The call was previously intimated to exchanges on February 6, 2026. The recording is hosted on the company's website and pertains to unaudited standalone and consolidated financial results. The filing is a routine disclosure under SEBI Listing Regulations, signed by Chairman & Managing Director Sudhir Vaid.
No direct impact on stock price; this is a routine compliance filing. Investors who want management commentary on Q3 results can listen to the recording for insights on performance and outlook.